Literature DB >> 2522304

Phospholipase A2 inhibitory activity in thymocytes of dexamethasone-treated mice--possible implication of lipocortins.

M Errasfa1, B Rothhut, F Russo-Marie.   

Abstract

The cellular phospholipase A2 activity of mouse thymocytes was estimated in vitro by the release of [3H]-Arachidonic acid from labeled and calcium ionophore A23187-stimulated cells. This activity was decreased in thymocytes from dexamethasone-treated mice. Thus, the presence of phospholipase A2 inhibitory proteins in mouse thymus was investigated. Three main proteins (36 kDa I, 36 kDa II, 73 kDa) were purified. These proteins were able to inhibit both phospholipase A2 in vitro, and the release of [3H]-Arachidonic acid from labeled and stimulated mouse thymocytes. Biochemical analysis revealed that the three proteins were lipocortin-like proteins. Our results show that in vivo dexamethasone treatment induces a phospholipase A2 inhibitory activity in mouse thymus, such an inhibition can be reproduced on isolated thymocytes by purified thymic lipocortins, known as glucocorticosteroid-inducible proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522304     DOI: 10.1016/0006-291x(89)92403-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Elevation of oleate-activated phospholipase D activity during thymic atrophy.

Authors:  Youngkyun Lee; Soo-Mee Song; Heung Soon Park; Sungyeol Kim; Eun-Hee Koh; Myung Sun Choi; Myung-Un Choi
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice.

Authors:  M Errasfa; F Russo-Marie
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

3.  Lack of involvement of lipocortin 1 in dexamethasone suppression of IL-1 release.

Authors:  E F Morand; D Rickard; N J Goulding
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.